You are a research scientist for the pharmaceutical company AstraZeneca working on a tumor-agnostic treatment for lung cancer. This treatment will be based on which of the following?
A. The blood type of the patient.
B. The type of lung tissue in which the cancer originated.
C. The size of the tumor.
D. The cancer's genetic make-up.